Aquestive Therapeutics, Inc. AQST Deferred Tax Assets, Net of Valuation Allowance
Deferred Tax Assets, Net of Valuation Allowance at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsNet.
The official record: Aquestive Therapeutics, Inc.’s 10-K, filed March 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s deferred tax assets, net of valuation allowance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s deferred tax assets, net of valuation allowance?
- Aquestive Therapeutics, Inc. (AQST) reported deferred tax assets, net of valuation allowance of $0 in Q4 2025.